PL3369732T3 - Związki modulujące receptor androgenowy - Google Patents

Związki modulujące receptor androgenowy

Info

Publication number: PL3369732T3
Authority: PL; Poland
Prior art keywords: androgen receptor; compounds modulating; modulating; compounds; androgen
Prior art date: 2009-10-27

Application number

PL18163765T

Other languages

English (en)

Inventor

Gerd Wohlfahrt

Olli Törmäkangas

Arja Karjalainen

Pia Knuuttila

Patrik Holm

Sirpa Rasku

Anniina Vesalainen

Harri Salo

Lisa Höglund

Original Assignee

Orion Corporation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-10-27

Filing date

2010-10-27

Publication date

2021-12-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43383475&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3369732(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-10-27 Application filed by Orion Corporation filed Critical Orion Corporation

2021-12-06 Publication of PL3369732T3 publication Critical patent/PL3369732T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/44—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
- A01N37/46—N-acyl derivatives
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/36—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/54—1,3-Diazines; Hydrogenated 1,3-diazines
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/64—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
- A01N43/647—Triazoles; Hydrogenated triazoles
- A01N43/653—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
- A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Dentistry (AREA)
Plant Pathology (AREA)
Wood Science & Technology (AREA)
Pest Control & Pesticides (AREA)
Zoology (AREA)
Agronomy & Crop Science (AREA)
Environmental Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL18163765T 2009-10-27 2010-10-27 Związki modulujące receptor androgenowy PL3369732T3 (pl)

Applications Claiming Priority (6)

Application Number	Priority Date	Filing Date	Title
US25515909P	2009-10-27	2009-10-27
EP10781918.7A EP2493858B1 (en)	2009-10-27	2010-10-27	Androgen receptor modulating compounds
EP18163765.3A EP3369732B1 (en)	2009-10-27	2010-10-27	Androgen receptor modulating compounds
EP16157716.8A EP3056485B1 (en)	2009-10-27	2010-10-27	Androgen receptor modulating compounds
EP14162075.7A EP2754656A1 (en)	2009-10-27	2010-10-27	Androgen receptor modulating compounds
PCT/FI2010/000065 WO2011051540A1 (en)	2009-10-27	2010-10-27	Androgen receptor modulating compounds

Publications (1)

Publication Number	Publication Date
PL3369732T3 true PL3369732T3 (pl)	2021-12-06

Family

ID=43383475

Family Applications (4)

Application Number	Title	Priority Date	Filing Date
PL16157716T PL3056485T3 (pl)	2009-10-27	2010-10-27	Związki modulujące receptor androgenowy
PL21169615.8T PL3885340T3 (pl)	2009-10-27	2010-10-27	Związki modulujące receptor androgenowy
PL18163765T PL3369732T3 (pl)	2009-10-27	2010-10-27	Związki modulujące receptor androgenowy
PL10781918T PL2493858T3 (pl)	2009-10-27	2010-10-27	Związki modulujące receptor androgenowy

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
PL16157716T PL3056485T3 (pl)	2009-10-27	2010-10-27	Związki modulujące receptor androgenowy
PL21169615.8T PL3885340T3 (pl)	2009-10-27	2010-10-27	Związki modulujące receptor androgenowy

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL10781918T PL2493858T3 (pl)	2009-10-27	2010-10-27	Związki modulujące receptor androgenowy

Country Status (37)

Country	Link
US (5)	US8975254B2 (pl)
EP (5)	EP2754656A1 (pl)
JP (1)	JP5763083B2 (pl)
KR (2)	KR101654529B1 (pl)
CN (2)	CN105061313B (pl)
AR (1)	AR078793A1 (pl)
AU (1)	AU2010311299C1 (pl)
BR (1)	BR112012008823B8 (pl)
CA (1)	CA2777896C (pl)
CL (1)	CL2012000772A1 (pl)
CO (1)	CO6531494A2 (pl)
CY (2)	CY2020010I2 (pl)
DK (4)	DK3056485T3 (pl)
EA (1)	EA021170B1 (pl)
ES (4)	ES2877248T3 (pl)
FI (1)	FI3885340T3 (pl)
GE (1)	GEP20166472B (pl)
HR (4)	HRP20241681T1 (pl)
HU (4)	HUE039390T2 (pl)
IL (2)	IL218586A (pl)
LT (4)	LT3056485T (pl)
LU (1)	LUC00154I2 (pl)
MX (1)	MX2012004867A (pl)
MY (1)	MY159924A (pl)
NL (1)	NL301041I2 (pl)
NO (1)	NO2020018I1 (pl)
NZ (1)	NZ598747A (pl)
PE (1)	PE20121058A1 (pl)
PH (1)	PH12012500782A1 (pl)
PL (4)	PL3056485T3 (pl)
PT (4)	PT3885340T (pl)
RS (4)	RS53469B (pl)
SI (4)	SI3056485T1 (pl)
SM (3)	SMT202100480T1 (pl)
UA (1)	UA109535C2 (pl)
WO (1)	WO2011051540A1 (pl)
ZA (1)	ZA201202655B (pl)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP5996532B2 (ja) *	2010-07-15	2016-09-21	バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒＩｎｔｅｌｌｅｃｔｕａｌＰｒｏｐｅｒｔｙＧｍｂＨ	有害生物防除剤としての新規複素環式化合物
ES2541295T3 (es) *	2011-04-21	2015-07-17	Orion Corporation	Carboxamidas que modulan el receptor de andrógenos
EP2574607A1 (en) *	2011-09-06	2013-04-03	F. Hoffmann-La Roche AG	PDE10 modulators
EA028062B1 (ru) *	2012-03-15	2017-10-31	СИГНАЛ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи	Лечение рака ингибиторами tor киназы
KR20140138931A (ko) *	2012-03-23	2014-12-04	니혼노야쿠가부시키가이샤	티아졸카르복사미드 유도체 및 그 사용 방법
KR20150023390A (ko)	2012-06-15	2015-03-05	다이쇼 세이야꾸 가부시끼가이샤	분지쇄 알킬 헤테로 방향환 유도체
AU2013305759C1 (en)	2012-08-23	2018-01-18	Janssen Biopharma, Inc.	Compounds for the treatment of paramoxyvirus viral infections
CN102952095A (zh) *	2012-10-19	2013-03-06	盛世泰科生物医药技术(苏州)有限公司	一种2-羧酸乙酯-5-溴甲基噻唑的合成方法
EA038819B1 (ru) *	2013-08-21	2021-10-25	Алиос Биофарма, Инк.	Противовирусные соединения
WO2015172196A1 (en) *	2014-05-13	2015-11-19	Monash University	Heterocyclic compounds and use of same
US12312316B2 (en)	2015-01-20	2025-05-27	Arvinas Operations, Inc.	Compounds and methods for the targeted degradation of androgen receptor
KR102564925B1 (ko)	2015-01-20	2023-08-07	아비나스 오퍼레이션스, 인코포레이티드	안드로겐 수용체의 표적화된 분해를 위한 화합물 및 방법
DK3250554T3 (da)	2015-01-30	2022-06-27	Orion Corp	Carboxamidderivat og diastereomerer deraf i stabil, krystallinsk form
MA41614A (fr) *	2015-02-25	2018-01-02	Alios Biopharma Inc	Composés antiviraux
US10189789B2 (en)	2015-04-09	2019-01-29	Orion Corporation	Process for the preparation of androgen receptor antagonists and intermediates thereof
EP3297437A4 (en) *	2015-05-18	2019-02-27	Translational Drug Development Llc	HETEROCYCLIC COMPOUNDS AS INHIBITORS OF KINASES
CN107056755B (zh) *	2015-12-07	2019-02-22	苏州信诺维医药科技有限公司	五元杂环酰胺类wnt通路抑制剂
CN107286094A (zh) *	2016-04-12	2017-10-24	常州爱诺新睿医药技术有限公司	一种bay-1841788与药用辅料的固体分散体及其制备方法
JP6716023B2 (ja)	2016-08-26	2020-07-01	クリスタルファーマシューティカル（スーチョウ）カンパニー，リミテッド	アンドロゲン受容体拮抗薬の結晶形及びその製造方法並びに用途
KR20250044800A (ko)	2016-10-11	2025-04-01	아비나스 오퍼레이션스, 인코포레이티드	안드로겐 수용체의 표적 분해용 화합물 및 방법
FI3592732T3 (fi) *	2017-03-07	2025-05-28	Orion Corp	Kiteisen farmaseuttisen tuotteen valmistus
US11185549B2 (en)	2017-06-28	2021-11-30	Bayer Consumer Care Ag	Combination of a PI3K-inhibitor with an androgen receptor antagonist
WO2019028689A1 (zh)	2017-08-09	2019-02-14	杭州领业医药科技有限公司	Odm-201晶型及其制备方法和药物组合物
CN107602471B (zh) *	2017-09-22	2021-04-27	成都恒汇化成医药科技有限公司	一种达罗鲁胺的晶型制备方法
JP2021515040A (ja) *	2018-02-27	2021-06-17	サンド・アクチエンゲゼルシヤフト	ダロルタミドの結晶形態ｉｉ
JP2021535200A (ja) *	2018-08-13	2021-12-16	ナショナル・センター・フォー・バイオロジカル・サイエンス−ティーアイエフアール	治療的介入のためのＨＩＶ−１Ｎｅｆ−ＣＤ８０／ＣＤ８６相互作用を標的化する阻害剤
US20210386826A1 (en)	2018-11-05	2021-12-16	Pfizer Inc.	Combination for Treating Cancer
WO2020157699A1 (en)	2019-01-30	2020-08-06	Aragon Pharmaceuticals, Inc.	Anti-androgens for the treatment of metastatic castration-sensitive prostate cancer
WO2020173457A1 (zh) *	2019-02-27	2020-09-03	深圳市塔吉瑞生物医药有限公司	取代的吡唑类化合物及包含该化合物的组合物及其用途
JP7577698B2 (ja)	2019-07-02	2024-11-05	オリオンコーポレーション	ダロルタミドの医薬組成物
CN110590668A (zh) *	2019-07-17	2019-12-20	江苏君若医药有限公司	N-[(1s)-2-[3-(3-氯-4-氰基苯基)-1h-吡唑-1-基]-1-甲基乙基]-5-(1-羟基乙基)- 1h-吡唑-3-甲酰胺的制备方法
JP7526783B2 (ja)	2019-08-08	2024-08-01	ラークナ・リミテッド	癌を処置する方法
CN111116476A (zh) *	2019-12-27	2020-05-08	武汉九州钰民医药科技有限公司	制备抗肿瘤药物多拉米胺的方法
EP4146642A1 (en)	2020-05-09	2023-03-15	Arvinas Operations, Inc.	Methods of manufacturing a bifunctional compound, ultrapure forms of the bifunctional compound, and dosage forms comprising the same
AU2021269870A1 (en)	2020-05-11	2023-01-19	Orion Corporation	Method for the preparation of androgen receptor antagonists and intermediates thereof
CA3188821A1 (en)	2020-08-13	2022-02-17	Lars ANDERS	Combination therapy
CN111978534B (zh) *	2020-09-07	2022-05-31	陕西师范大学	一种含苯并咪唑液晶基元的侧链型液晶离聚物及其制备方法
EP4313034A1 (en)	2021-03-24	2024-02-07	Pfizer Inc.	Combination of talazoparib and an anti-androgen for the treatment of ddr gene mutated metastatic castration-sensitive prostate cancer
US20240208991A1 (en) *	2021-08-04	2024-06-27	Lg Chem, Ltd.	Novel compound and organic light emitting device comprising the same
CN113527208A (zh) *	2021-08-31	2021-10-22	江西金丰药业有限公司	一步法制备2-氯-4-（1h-吡唑-3-基）苯甲腈的方法
CN113861115A (zh) *	2021-09-10	2021-12-31	浙江师范大学	一种吡唑酰胺类衍生物及合成方法和应用
MX2024009980A (es)	2022-02-28	2024-08-26	Quim Sintetica S A	Forma cristalina de darolutamida.
JP2023140319A (ja)	2022-03-22	2023-10-04	アッヴィ・インコーポレイテッド	ブルトン型チロシンキナーゼを分解するためのピリミジン
US20250235448A1 (en)	2022-04-07	2025-07-24	Astrazeneca Ab	Combination therapy for treating cancer
TWI883565B (zh)	2022-10-02	2025-05-11	美商輝瑞大藥廠	用於治療轉移性去勢抵抗性前列腺癌之他拉唑帕尼及恩雜魯胺之組合
WO2024121163A1 (en)	2022-12-06	2024-06-13	Cancer Research Technology Limited	Combination of 10d1f and an androgen inhibitor for treatment and prevention of cancers
TW202425976A (zh)	2022-12-17	2024-07-01	美商輝瑞大藥廠	用於治療轉移性去勢抵抗性前列腺癌之他拉唑帕尼及恩雜魯胺之組合
TW202521513A (zh)	2023-08-17	2025-06-01	芬蘭商奧利安公司	雄性素受體拮抗劑及其中間物之製備方法
CN117776973A (zh) *	2023-09-20	2024-03-29	山东特珐曼药业有限公司	一种4-甲酰基-3-甲氧基苯甲腈的制备方法
US12496301B2 (en)	2023-12-08	2025-12-16	Arvinas Operations, Inc.	Use of androgen receptor degrader for the treatment of spinal and bulbar muscular atrophy
WO2025146444A1 (en)	2024-01-03	2025-07-10	Bayer Aktiengesellschaft	Darolutamide in combination with braf and mek inhibitors for melanoma treatment
WO2025229051A1 (en)	2024-05-03	2025-11-06	F. Hoffmann-La Roche Ag	Use of atr inhibitors in combination with antiandrogen agent

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0100172B1 (en)	1982-07-23	1987-08-12	Imperial Chemical Industries Plc	Amide derivatives
FR2656609B1 (fr)	1989-12-28	1992-03-27	Synthelabo	Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique.
US5578550A (en)	1993-10-08	1996-11-26	American Cyanamid Company	Herbicidal oxadiazole carbonamide compounds
FR2741342B1 (fr)	1995-11-22	1998-02-06	Roussel Uclaf	Nouvelles phenylimidazolidines fluorees ou hydroxylees, procede, intermediaires de preparation, application comme medicaments, nouvelle utilisation et compositions pharmaceutiques
BR9914018A (pt)	1998-09-22	2001-07-03	Yamanouchi Pharmaceuticals Co	Derivado de cianofenila
BR0213817A (pt)	2001-11-02	2004-10-19	Pfizer Prod Inc	Tratamento de sìndrome de resistência à insulina e diabete do tipo 2 com inibidores da pde9
MXPA04006184A (es) *	2001-12-28	2004-12-06	Bayer Pharmaceuticals Corp	Compuestos derivados de 1h-pirazolilo, para el uso en enfermedades asociadas con el receptor 5-ht2c.
EP1466902A4 (en)	2001-12-28	2005-11-09	Takeda Pharmaceutical	ANTAGONISTS OF THE ANDROGEN RECEPTOR
MXPA04005847A (es) *	2001-12-28	2004-09-13	Bayer Pharmaceuticals Corp	Compuestos derivados de 4-sulfuro/sulfoxido/sulfonil-1h-pirazolilo, para uso en enfermedades asociadas con el receptor 5-ht2c.
AU2003217870A1 (en)	2002-03-01	2003-09-16	Pintex Pharmaceuticals, Inc.	Pini-modulating compounds and methods of use thereof
AR040149A1 (es) *	2002-06-07	2005-03-16	Novartis Ag	Compuestos de aminoacetonitrilo, un proceso para su preparacion, composicion, y uso del compuesto
CN1684957A (zh) *	2002-08-02	2005-10-19	阿根塔发明有限公司	作为组蛋白脱乙酰酶抑制剂的取代的噻吩基－异羟肟酸
DE10322108B4 (de)	2003-05-09	2008-12-11	Bayer Schering Pharma Aktiengesellschaft	Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit
EP1634874A4 (en)	2003-06-12	2008-04-02	Chugai Pharmaceutical Co Ltd	imidazolidine
EP1663953A1 (en)	2003-09-24	2006-06-07	Methylgene, Inc.	Inhibitors of histone deacetylase
EP1790640A4 (en)	2004-09-09	2009-07-29	Chugai Pharmaceutical Co Ltd	NEW IMIDAZOLIDINE DERIVATIVE AND APPLICATION THEREOF
JP2008007405A (ja) *	2004-12-07	2008-01-17	Takeda Chem Ind Ltd	カルボキサミド誘導体
EP1710237A1 (en) *	2005-04-08	2006-10-11	Bayer CropScience S.A.	New heterocyclylethylbenzamide derivatives
KR101782236B1 (ko)	2005-05-13	2017-09-26	더 리전트 오브 더 유니버시티 오브 캘리포니아	디아릴히단토인 화합물
US7709516B2 (en)	2005-06-17	2010-05-04	Endorecherche, Inc.	Helix 12 directed non-steroidal antiandrogens
AR057656A1 (es)	2005-07-01	2007-12-12	Ligand Pharm Inc	Compuestos moduladores de receptores de androgeno y metodods relacionados
GB0518237D0 (en) *	2005-09-07	2005-10-19	Angeletti P Ist Richerche Bio	Therapeutic compounds
WO2007056155A1 (en) *	2005-11-03	2007-05-18	Chembridge Research Laboratories, Inc.	Heterocyclic compounds as tyrosine kinase modulators
TW200800997A (en)	2006-03-22	2008-01-01	Astrazeneca Ab	Chemical compounds
JP5205274B2 (ja)	2006-11-22	2013-06-05	日本農薬株式会社	新規なピラゾール誘導体、有害生物防除剤及びその使用方法
WO2008124000A2 (en) *	2007-04-02	2008-10-16	Ligand Pharmaceuticals Incorporated	Thiazole derivatives as androgen receptor modulator compounds
JP2010532381A (ja) *	2007-06-29	2010-10-07	サネシスファーマシューティカルズ，インコーポレイテッド	Ｒａｆキナーゼ阻害剤として有用な複素環式化合物
WO2009028543A1 (ja)	2007-08-30	2009-03-05	Takeda Pharmaceutical Company Limited	置換ピラゾール誘導体
UY31432A1 (es)	2007-10-26	2009-05-29		Compuestos de diarilhidantoina
US20090270361A1 (en)	2008-03-26	2009-10-29	Takeda Pharmaceutical Company Limited	Substituted pyrazole derivatives and use thereof
JP2011524894A (ja) *	2008-06-18	2011-09-08	ファイザー・リミテッド	ニコチンアミド誘導体

2010
- 2010-10-26 AR ARP100103942A patent/AR078793A1/es active IP Right Grant
- 2010-10-27 KR KR1020127013214A patent/KR101654529B1/ko active Active
- 2010-10-27 PH PH1/2012/500782A patent/PH12012500782A1/en unknown
- 2010-10-27 LT LTEP16157716.8T patent/LT3056485T/lt unknown
- 2010-10-27 EP EP14162075.7A patent/EP2754656A1/en not_active Withdrawn
- 2010-10-27 HU HUE16157716A patent/HUE039390T2/hu unknown
- 2010-10-27 LT LTEP18163765.3T patent/LT3369732T/lt unknown
- 2010-10-27 DK DK16157716.8T patent/DK3056485T3/en active
- 2010-10-27 ES ES18163765T patent/ES2877248T3/es active Active
- 2010-10-27 PT PT211696158T patent/PT3885340T/pt unknown
- 2010-10-27 PL PL16157716T patent/PL3056485T3/pl unknown
- 2010-10-27 HR HRP20241681TT patent/HRP20241681T1/hr unknown
- 2010-10-27 PL PL21169615.8T patent/PL3885340T3/pl unknown
- 2010-10-27 NZ NZ598747A patent/NZ598747A/xx unknown
- 2010-10-27 UA UAA201206302A patent/UA109535C2/ru unknown
- 2010-10-27 HU HUE18163765A patent/HUE055528T2/hu unknown
- 2010-10-27 US US13/504,511 patent/US8975254B2/en active Active
- 2010-10-27 SM SM20210480T patent/SMT202100480T1/it unknown
- 2010-10-27 EP EP10781918.7A patent/EP2493858B1/en active Active
- 2010-10-27 PE PE2012000424A patent/PE20121058A1/es active IP Right Grant
- 2010-10-27 DK DK21169615.8T patent/DK3885340T3/da active
- 2010-10-27 ES ES10781918.7T patent/ES2486263T3/es active Active
- 2010-10-27 CN CN201510501603.4A patent/CN105061313B/zh active Active
- 2010-10-27 FI FIEP21169615.8T patent/FI3885340T3/fi active
- 2010-10-27 JP JP2012535889A patent/JP5763083B2/ja active Active
- 2010-10-27 SM SM20240534T patent/SMT202400534T1/it unknown
- 2010-10-27 WO PCT/FI2010/000065 patent/WO2011051540A1/en not_active Ceased
- 2010-10-27 EP EP16157716.8A patent/EP3056485B1/en active Active
- 2010-10-27 SI SI201031718T patent/SI3056485T1/en unknown
- 2010-10-27 CA CA2777896A patent/CA2777896C/en active Active
- 2010-10-27 RS RS20140420A patent/RS53469B/sr unknown
- 2010-10-27 CN CN201080048340.1A patent/CN102596910B/zh active Active
- 2010-10-27 HR HRP20140919AT patent/HRP20140919T1/hr unknown
- 2010-10-27 RS RS20210903A patent/RS62123B1/sr unknown
- 2010-10-27 BR BR112012008823A patent/BR112012008823B8/pt active IP Right Grant
- 2010-10-27 RS RS20180913A patent/RS57592B1/sr unknown
- 2010-10-27 MY MYPI2012001441A patent/MY159924A/en unknown
- 2010-10-27 HU HUE21169615A patent/HUE069657T2/hu unknown
- 2010-10-27 EP EP21169615.8A patent/EP3885340B1/en active Active
- 2010-10-27 PT PT181637653T patent/PT3369732T/pt unknown
- 2010-10-27 PL PL18163765T patent/PL3369732T3/pl unknown
- 2010-10-27 AU AU2010311299A patent/AU2010311299C1/en active Active
- 2010-10-27 LT LTEP21169615.8T patent/LT3885340T/lt unknown
- 2010-10-27 DK DK18163765.3T patent/DK3369732T3/da active
- 2010-10-27 ES ES21169615T patent/ES2997997T3/es active Active
- 2010-10-27 PT PT161577168T patent/PT3056485T/pt unknown
- 2010-10-27 ES ES16157716.8T patent/ES2678073T3/es active Active
- 2010-10-27 PT PT107819187T patent/PT2493858E/pt unknown
- 2010-10-27 MX MX2012004867A patent/MX2012004867A/es active IP Right Grant
- 2010-10-27 EA EA201270597A patent/EA021170B1/ru active Protection Beyond IP Right Term
- 2010-10-27 PL PL10781918T patent/PL2493858T3/pl unknown
- 2010-10-27 SI SI201032153T patent/SI3885340T1/sl unknown
- 2010-10-27 RS RS20241370A patent/RS66289B1/sr unknown
- 2010-10-27 DK DK10781918.7T patent/DK2493858T3/da active
- 2010-10-27 GE GEAP201012722A patent/GEP20166472B/en unknown
- 2010-10-27 SI SI201032078T patent/SI3369732T1/sl unknown
- 2010-10-27 SI SI201030739T patent/SI2493858T1/sl unknown
- 2010-10-27 EP EP18163765.3A patent/EP3369732B1/en active Active
- 2010-10-27 KR KR1020167023703A patent/KR101670299B1/ko active Active
2012
- 2012-03-12 IL IL218586A patent/IL218586A/en active IP Right Grant
- 2012-03-28 CL CL2012000772A patent/CL2012000772A1/es unknown
- 2012-04-12 ZA ZA2012/02655A patent/ZA201202655B/en unknown
- 2012-04-27 CO CO12069611A patent/CO6531494A2/es active IP Right Grant
2014
- 2014-09-23 SM SM201400138T patent/SMT201400138B/xx unknown
2015
- 2015-01-16 US US14/598,973 patent/US9657003B2/en active Active
- 2015-03-30 IL IL238044A patent/IL238044A/en active IP Right Grant
2017
- 2017-04-13 US US15/486,995 patent/US10118933B2/en active Active
2018
- 2018-07-31 HR HRP20181229TT patent/HRP20181229T1/hr unknown
- 2018-09-25 US US16/140,716 patent/US10711013B2/en active Active
2020
- 2020-02-24 US US16/799,270 patent/US11046713B2/en active Active
- 2020-05-11 NL NL301041C patent/NL301041I2/nl unknown
- 2020-05-19 LU LU00154C patent/LUC00154I2/fr unknown
- 2020-05-26 HU HUS2000012C patent/HUS2000012I1/hu unknown
- 2020-06-05 CY CY2020010C patent/CY2020010I2/el unknown
- 2020-06-17 NO NO2020018C patent/NO2020018I1/no unknown
- 2020-06-26 LT LTPA2020514C patent/LTC2493858I2/lt unknown
2021
- 2021-07-22 HR HRP20211180TT patent/HRP20211180T1/hr unknown
- 2021-08-10 CY CY20211100717T patent/CY1124429T1/el unknown

Also Published As

Publication number	Publication date
ES2997997T3 (en)	2025-02-18
DK3885340T3 (da)	2025-01-06
US20190100536A1 (en)	2019-04-04
AU2010311299A1 (en)	2012-04-12
EP2493858A1 (en)	2012-09-05
KR101670299B1 (ko)	2016-10-28
IL218586A (en)	2015-10-29
US20150203479A1 (en)	2015-07-23
RS62123B1 (sr)	2021-08-31
LUC00154I2 (pl)	2021-02-17
LTPA2020514I1 (lt)	2020-07-27
EP2493858B1 (en)	2014-07-02
ZA201202655B (en)	2012-12-27
CA2777896A1 (en)	2011-05-05
ES2678073T3 (es)	2018-08-08
FI3885340T3 (fi)	2025-02-03
RS53469B (sr)	2014-12-31
DK2493858T3 (da)	2014-09-08
LT3885340T (lt)	2024-12-27
DK3369732T3 (da)	2021-07-26
DK3056485T3 (en)	2018-07-30
AU2010311299C1 (en)	2023-02-02
PL3056485T3 (pl)	2018-12-31
KR101654529B1 (ko)	2016-09-06
AU2010311299A8 (en)	2012-06-14
AU2010311299B2 (en)	2014-07-17
PT3885340T (pt)	2024-12-16
SI3056485T1 (en)	2018-08-31
HUS2000012I1 (hu)	2020-07-28
BR112012008823B1 (pt)	2021-01-12
WO2011051540A9 (en)	2012-06-21
LUC00154I1 (pl)	2020-05-19
PT3056485T (pt)	2018-07-31
PL2493858T3 (pl)	2015-01-30
HUE039390T2 (hu)	2018-12-28
HUE069657T2 (hu)	2025-04-28
CY1124429T1 (el)	2022-07-22
PT3369732T (pt)	2021-07-06
IL218586A0 (en)	2012-05-31
PE20121058A1 (es)	2012-08-18
LTC2493858I2 (lt)	2022-03-25
US11046713B2 (en)	2021-06-29
BR112012008823A2 (pt)	2019-02-19
CY2020010I1 (el)	2020-11-25
MY159924A (en)	2017-02-15
CO6531494A2 (es)	2012-09-28
HK1173442A1 (zh)	2013-05-16
UA109535C2 (uk)	2015-09-10
CN105061313A (zh)	2015-11-18
EP3056485B1 (en)	2018-05-09
WO2011051540A1 (en)	2011-05-05
ES2877248T3 (es)	2021-11-16
CN102596910B (zh)	2015-11-25
AR078793A1 (es)	2011-12-07
JP2013508447A (ja)	2013-03-07
LT3369732T (lt)	2021-06-25
PH12012500782A1 (en)	2016-05-27
NO2020018I1 (no)	2020-06-17
HRP20211180T1 (hr)	2021-10-15
PT2493858E (pt)	2014-09-03
EP3369732A1 (en)	2018-09-05
US20120225867A1 (en)	2012-09-06
KR20120102057A (ko)	2012-09-17
US8975254B2 (en)	2015-03-10
LT3056485T (lt)	2018-07-25
CN105061313B (zh)	2017-07-18
SI2493858T1 (sl)	2014-10-30
RS57592B1 (sr)	2018-11-30
CN102596910A (zh)	2012-07-18
CA2777896C (en)	2017-05-23
SMT202400534T1 (it)	2025-01-14
HUE055528T2 (hu)	2021-12-28
JP5763083B2 (ja)	2015-08-12
EP2754656A1 (en)	2014-07-16
US20170260206A1 (en)	2017-09-14
NZ598747A (en)	2013-06-28
SI3369732T1 (sl)	2021-08-31
EP3369732B1 (en)	2021-05-26
MX2012004867A (es)	2012-06-08
US10118933B2 (en)	2018-11-06
IL238044A (en)	2016-07-31
CY2020010I2 (el)	2020-11-25
PL3885340T3 (pl)	2025-03-24
NL301041I2 (nl)	2020-09-14
GEP20166472B (en)	2016-05-10
SI3885340T1 (sl)	2025-02-28
HRP20181229T1 (hr)	2018-10-05
BR112012008823B8 (pt)	2021-05-25
EA021170B1 (ru)	2015-04-30
EP3056485A1 (en)	2016-08-17
KR20160105927A (ko)	2016-09-07
SMT202100480T1 (it)	2021-09-14
US10711013B2 (en)	2020-07-14
EP3885340A1 (en)	2021-09-29
CL2012000772A1 (es)	2012-08-24
ES2486263T3 (es)	2014-08-18
WO2011051540A8 (en)	2012-05-24
EP3885340B1 (en)	2024-11-27
US9657003B2 (en)	2017-05-23
RS66289B1 (sr)	2025-01-31
HRP20140919T1 (hr)	2014-11-21
US20200299307A1 (en)	2020-09-24
SMT201400138B (it)	2014-11-10
HRP20241681T1 (hr)	2025-02-28
EA201270597A1 (ru)	2012-10-30

Publication	Publication Date	Title
LTC2493858I2 (lt)	2022-03-25	Androgeno receptorių moduliuojantys junginiai
DK2427449T3 (da)	2013-04-22	Vinylindazolylforbindelser
BR112012006859A2 (pt)	2019-09-24	compostos
BRPI1013614A2 (pt)	2019-09-24	compostos substituídos de espiro-amida
EP2490698A4 (en)	2013-09-25	MODULATION OF AXONES DEGENERATION
BRPI1005525A2 (pt)	2016-02-23	compostos de azaazuleno
BRPI1011668A2 (pt)	2016-03-22	compostos que modulam seletivamente o receptor cb2
DK2512451T3 (da)	2016-06-06	Modulator
UY33156A (es)	2011-07-29	Nuevos compuestos tienopirrol
SMT201600139B (it)	2016-07-01	Composti anticancro
EP2394990A4 (en)	2013-09-11	INDOLINE DERIVATIVES
BR112012006693A2 (pt)	2015-09-08	combinação
BR112012006968A2 (pt)	2019-09-24	combinação
BRPI1009199A2 (pt)	2016-03-08	compostos de pirazinoisoquinolina
BRPI1014080A2 (pt)	2015-08-25	Compostos substituidos de enaminocarbolina
FIU20090444U0 (fi)	2009-12-04	Levityslaite
FI8510U1 (fi)	2009-11-07	Sovitelma julkisivua varten
FI8708U1 (fi)	2010-05-10	Kulkuaukko
FIU20100266U0 (fi)	2010-06-02	Kiristysmekanismi